INFUSE BONE GRAFT
Report
- Report Number
- 1030489-2013-02027
- Event Type
- Injury
- Date Received
- May 31, 2013
- Report Date
- October 25, 2017
- Manufacturer
- MEDTRONIC SOFAMOR DANEK USA, INC
- Product Code
- NEK
- PMA / PMN Number
- P000058
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- ATTORNEY
Narratives
(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IT WAS REPORTED THAT THE PATIENT SUSTAINED UNSPECIFIED INJURIES FOLLOWING THE USE OF RHBMP-2/ACS IN AN UNSPECIFIED SPINAL FUSION SURGERY. NO ADDITIONAL INFORMATION WAS REPORTED.
IT WAS REPORTED THAT ON (B)(6) 2008, THE PATIENT UNDERWENT FUSION SURGERY IN WHICH RH-BMP2/ACS WAS USED. AS PER OP-NOTES, ¿THE CARTILAGINOUS END PLATES OF L3 AND L4 WERE DECORTICATED WITH A SMALL RASP. THE DEPTH AND HEIGHT OF THE DISK SPACE WAS MEASURED BY INSERTING VARIOUS TRIAL INTERBODY SPACERS AND A 10 MM LORDOTIC INTERBODY CAGE WAS CHOSEN AS THE OPTIMAL FIT. THIS WAS PACKED WITH A COMBINATION OF RHBMP-2 AND GRAFT SUBSTITUTE, WHICH WAS THEN INSERTED INTO THE CAGE. THE CAGE WAS THEN IMPACTED INTO THE L3-L4 DISK SPACE UNDER FLUOROSCOPIC GUIDANCE. THE LOCATION OF THE CAGE WAS EXCELLENT IN BOTH SAGITTAL AND CORONAL PLANES.¿ THE PATIENT TOLERATED THE PROCEDURE WELL AND THERE WERE NO INTRA-OPERATIVE COMPLICATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 241952 | INFUSE BONE GRAFT | FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET | NEK | MEDTRONIC SOFAMOR DANEK USA, INC | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |